Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 201

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Toward clinically applicable biomarkers for asthma: An EAACI position paper

Open access
Diamant, Zuzana, Vijverberg, Susanne, Alving, Kjell, Bakirtas, Arzu, Bjermer, Leif, Custovic, Adnan, Dahlen, Sven‐Erik, Gaga, Mina, Gerth van Wijk, Roy, Del Giacco, Stefano, Hamelmann, Eckard, Heaney, Liam G., Heffler, Enrico, Kalayci, Ömer, Kostikas, Konstantinos, Lutter, Rene, Olin, Anna‐Carin, Sergejeva, Svetlana, Simpson, Angela, Sterk, Peter J., Tufvesson, Ellen, Agache, Ioana, Seys, Sven F.·2019·Allergy

Abstract

Inflammation, structural, and functional abnormalities within the airways are key features of asthma. Although these processes are well documented, their expression varies across the heterogeneous spectrum of asthma. Type 2 inflammatory responses are characterized by increased levels of eosinophils, Fe NO, and type 2 cytokines in blood and/or airways. Presently, type 2 asthma is the best‐defined endotype, typically found in patients with allergic asthma, but surprisingly also in nonallergic patients with (severe) asthma. The etiology of asthma with non‐type 2 inflammation is less clear. During the past decade, targeted therapies, including biologicals and small molecules, have been increasingly integrated into treatment strategies of severe asthma. These treatments block specific inflammatory pathways or single mediators. Single or composite biomarkers help to identify patients who will benefit from these treatments. So far, only a few inflammatory biomarkers have been validated for clinical application. The European Academy of Allergy & Clinical Immunology Task Force on Biomarkers in Asthma was initiated to review different biomarker sampling methods and to investigate clinical applicability of new and existing inflammatory biomarkers (point‐of‐care) to support diagnosis, targeted treatment, and monitoring of severe asthma. Subsequently, we discuss existing and novel targeted therapies for asthma as well as applicable biomarkers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/all.13806

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 201

Metadata

Authors
Diamant, Z., Vijverberg, S., Alving, K., Bakirtas, A., Bjermer, L., Custovic, A., Dahlen, S., Gaga, M., Gerth van Wijk, R., Del Giacco, S., Hamelmann, E., Heaney, L. G., Heffler, E., Kalayci, Ö., Kostikas, K., Lutter, R., Olin, A., Sergejeva, S., Simpson, A., Sterk, P. J., Tufvesson, E., Agache, I., & Seys, S. F.
Venue
Allergy
Publisher
Wiley
Published
2019-10
Volume
74
Issue
10
Pages
1835-1851
ISSN
  • 0105-4538 (ISSN-L)
  • 1398-9995
OpenAlex
W2929943519
Cited by
201
References
8
FWCI
14.86
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Toward clinically applicable biomarkers for asthma: An EAACI position paper. https://app.cochat.ai/papers/10.1111/all.13806
The paper
Diamant, Z., Vijverberg, S., Alving, K., Bakirtas, A., Bjermer, L., Custovic, A., Dahlen, S., Gaga, M., Gerth van Wijk, R., Del Giacco, S., Hamelmann, E., Heaney, L. G., Heffler, E., Kalayci, Ö., Kostikas, K., Lutter, R., Olin, A., Sergejeva, S., Simpson, A., . . . Seys, S. F. (2019). Toward clinically applicable biomarkers for asthma: An EAACI position paper. Allergy. https://doi.org/10.1111/all.13806

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.